Immupharma

(IMM)
Sector: Pharmaceuticals & Biotechnology
1.55p
-0.02p -0.96
Last updated: 12:17:32

Share information

Name Immupharma
Epic IMM
Isin GB0033711010
Index AIM100 AIM350
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 1.55p Net gearing n/a
Market capitalisation £6.45 Debt ratio n/a
Shares in issue 416.44 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -147.78
Dividend cover n/a EPS growth n/a
Earning per share -1.26 52-week high / low 0.85p / 2.61p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Immupharma
Address One Bartholomew Close, London, United Kingdom, EC1A 7BL
Telephone +44 20 7152 4080
Website http://www.immupharma.co.uk/

Directors

Director Position
Mr Timothy Paul McCarthy CEO
Mr Sébastien Goudreau Non-Executive Director
Ms Lisa Baderoon Non-Executive Director
Dr. Laurence Reilly Senior Independent Non-Executive Director
Dr Tim Franklin Chief Operating Officer

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 0.47 0.48 0.48
Investments and other non-current assets n/a n/a n/a
Total non-current assets 1.64 2.65 3.49
Inventory / work in progress n/a n/a n/a
Trade and other receivables 0.72 0.43 0.16
Cash and equivalents 0.67 1.65 5.86
Other current assets and asset held for resale 0.95 1.27 1.4
Total of all assets 3.97 6 10.92
Liabilities £ (m) 2022 2021 2020
Short term liabilities 1.45 1.58 1.26
Long term liabilities n/a n/a n/a
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 1.45 1.58 1.26
Net assets £ (m) 2022 2021 2020
Net assets 2.52 4.41 9.65
Equity £ (m) 2022 2021 2020
Share capital 28.98 28.5 25.02
Minority interests n/a n/a n/a
Retained earnings -61.12 -56.58 -45.97
Share premium account 28.79 27.24 27.24
Total equity 2.52 4.41 9.65
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -3.03 -6.59 -5.59
Pre-tax profit -4.46 -8.94 -7.25